Fei Xia

Risk factors for adverse clinical outcomes with COVID-19 in China: a multicenter, retrospective, observational study

Peng Xu, Rong Hua Tian, Song Luo et al. · Theranostics · 2020 · 138 citations · Full text

A New Simple Method for Isolation of Microvascular Endothelial Cells Avoiding Both Chemical and Mechanical Injuries

Fei Xia, Shaohua Li · Microvascular Research · 1995 · 98 citations

Mechanobiology, Tissue Engineering, Vascular Grafts +15

Psychological morbidities and fatigue in patients with confirmed COVID-19 during disease outbreak: prevalence and associated biopsychosocial risk factors

Rongfeng Qi, Wei Chen, Saiduo Liu et al. · 2020 · 90 citations · Full text

Resveratrol Inhibits CD4+ T Cell Activation by Enhancing the Expression and Activity of Sirt1

Ting Zou, Yi Yang, Fei Xia et al. · PLoS ONE · 2013 · 87 citations · Full text

Immunology, Cell Death, Pathology +17

Linezolid-resistant clinical isolates of enterococci and Staphylococcus cohnii from a multicentre study in China: molecular epidemiology and resistance mechanisms

Hongbin Chen, Weiyuan Wu, Ming Ni et al. · International Journal of Antimicrobial Agents · 2013 · 71 citations

Antimicrobial Resistance Gene, Pathogenic Microbiology, Health Sciences +11